Literature DB >> 16175591

Potential role of CB2 receptors in Cannabis smokers with chronic hepatitis C.

Robert F Schwabe, Soeren V Siegmund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16175591     DOI： 10.1002/hep.20895

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

Review 1.  Cannabinoids as novel anti-inflammatory drugs.

Authors:  Prakash Nagarkatti; Rupal Pandey; Sadiye Amcaoglu Rieder; Venkatesh L Hegde; Mitzi Nagarkatti
Journal:  Future Med Chem       Date:  2009-10       Impact factor: 3.808

Review 2.  Cannabis and the liver: Things you wanted to know but were afraid to ask.

Authors:  Julie Zhu; Kevork M Peltekian
Journal:  Can Liver J       Date:  2019-08-27

Review 3.  Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

Authors:  Rupal Pandey; Venkatesh L Hegde; Narendra P Singh; Lorne Hofseth; Uday Singh; Swapan Ray; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

4.  Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.

Authors:  Eleonora Patsenker; Philip Sachse; Andrea Chicca; María Salomé Gachet; Vreni Schneider; Johan Mattsson; Christian Lanz; Mathias Worni; Andrea de Gottardi; Mariam Semmo; Jochen Hampe; Clemens Schafmayer; Rudolf Brenneisen; Jürg Gertsch; Felix Stickel; Nasser Semmo
Journal:  Int J Mol Sci       Date:  2015-03-27       Impact factor: 5.923

5.  Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells.

Authors:  Christoph W Michalski; Milena Maier; Mert Erkan; Danguole Sauliunaite; Frank Bergmann; Pal Pacher; Sandor Batkai; Nathalia A Giese; Thomas Giese; Helmut Friess; Jörg Kleeff
Journal:  PLoS One       Date:  2008-02-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.